Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease

Peer review reports

Original Submission
29 Nov 2021	Submitted	Original manuscript
15 May 2022	Reviewed	Reviewer Report - Riaz Qureshi
14 Jul 2022	Author responded	Author comments - Emma Vermeulen
Resubmission - Version 2
14 Jul 2022	Submitted	Manuscript version 2
Publishing
18 Jul 2022	Editorially accepted
12 Sep 2022	Article published	10.1186/s13063-022-06562-9

Back to article page